Company profile: Scipher Medicine
1.1 - Company Overview
Company description
- Provider of a healthcare platform to determine which drug will work best for each patient, offering PrismRA, a blood test that predicts non-response to TNF inhibitors in rheumatoid arthritis; Spectra, a platform that discovers novel drug targets by analyzing patient molecular data and the human interactome; and PrismUC, a diagnostic test for ulcerative colitis utilizing molecular data to guide treatment decisions.
Products and services
- PrismRA: A molecular-signature-driven blood test that predicts non-response to TNF inhibitors in rheumatoid arthritis patients by identifying specific molecular signatures
- PrismUC: A molecular-data-guided diagnostic test for ulcerative colitis that utilizes patient molecular data to guide treatment decisions
- Spectra: An interactome-based platform that analyzes patient molecular data and the human interactome to discover novel drug targets.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Scipher Medicine
Ambrx
HQ: United States
Website
- Description: Provider of an expanded genetic code technology platform to discover and develop Engineered Precision Biologics, including next-generation ADCs, bispecific antibodies, targeted immuno-oncology therapies, novel cytokines and long-acting therapeutics; with clinical programs ARX788 for HER2-positive breast cancer and ARX517 for advanced prostate cancer, and partnerships to advance ADC oncology programs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ambrx company profile →
ChromaCode
HQ: United States
Website
- Description: Provider of HDPCR-based molecular diagnostics and bioinformatics solutions for tumor profiling, minimal residual disease detection, and decentralized disease monitoring, paired with cloud software for automated interpretation, remote analysis, and scalable deployment; offerings include a multiplexed NSCLC panel delivering results in 24 hours with high concordance to NGS.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ChromaCode company profile →
Integrated DNA Technologies
HQ: United States
Website
- Description: Provider of custom DNA and RNA oligonucleotides with various modifications; CRISPR-Cas9 reagents and tools for genome editing; gBlocks double-stranded gene fragments (125-3000 bp) for gene assembly, qPCR, and NGS; PrimeTime qPCR probes with dye and quencher options for multiplex gene expression analysis; and xGen DNA library prep kits for next-generation sequencing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Integrated DNA Technologies company profile →
Genomic Vision
HQ: France
Website
- Description: Provider of novel genetic tests and research tools for life sciences, developed and commercialized using Molecular Combing, a proprietary single DNA molecule detection technology, combined with biomarker discovery; focused on DNA analysis and genetic testing in cancer.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Genomic Vision company profile →
GenArraytion
HQ: United States
Website
- Description: Provider of medical diagnostics products and services for tick- and mosquito-borne disease and surveillance, epidemiology and source tracking, food and water testing, biodefense and environmental monitoring, including MultiFLEX Bioassays and Sniper Sequencing genotyping services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full GenArraytion company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Scipher Medicine
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Scipher Medicine
2.2 - Growth funds investing in similar companies to Scipher Medicine
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Scipher Medicine
4.2 - Public trading comparable groups for Scipher Medicine
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →